Personalized mRNA vaccines are poised to revolutionize cancer treatments. Here are the barriers. Pharma Voice | October 12, 2026

https://geneticliteracyproject.org/2026/10/12/personalized-mrna-vaccines-are-poised-to-revolutionize-cancer-treatments-here-are-the-barriers/ Personalized mRNA vaccines that train the immune system to hunt a patient’s own tumor mutations are nearing approval, but, as Pharma Voice’s Alexandra Pecci reports, building them may prove harder than discovering them. Merck and Moderna’s melanoma vaccine, intismeran autogene, recently met its primary endpoints in the phase 3 INTerpath-001 trial when paired with Keytruda.